Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of ProQR Therapeutics N.V (NASDAQ: PRQR) was $1.18 for the day, up 5.36% from the previous closing price of $1.12. In other words, the price has increased by $5.36 from its previous closing price. On the day, 0.99 million shares were traded.
Ratios:
Our analysis of PRQR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.95 and its Current Ratio is at 3.95. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.12.
On January 10, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $15.
Raymond James Upgraded its Outperform to Strong Buy on October 29, 2024, whereas the target price for the stock was revised from $6 to $14.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 6.08 while its Price-to-Book (P/B) ratio in mrq is 1.32.
Stock Price History:
Over the past 52 weeks, PRQR has reached a high of $4.62, while it has fallen to a 52-week low of $1.07. The 50-Day Moving Average of the stock is -36.72%, while the 200-Day Moving Average is calculated to be -49.40%.
Shares Statistics:
A total of 102.71M shares are outstanding, with a floating share count of 70.76M. Insiders hold about 32.74% of the company’s shares, while institutions hold 42.77% stake in the company.
